Liquid Biopsy Based NGS in Newly Diagnosed NSCLC

This study expands the application of an electronic health record (EHR) \"nudge\" used to prompt physicians\' clinical practice to order molecular testing at the time of initial diagnosis for patients with specific types of advanced lung cancer. The primary goal is to have these test results available prior to starting treatment so that physicians can make molecularly-informed treatment decisions. The second goal is to better understand factors that contribute to whether or not the EHR-nudge implementation is successful.